Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.

Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.

Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.

Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.

Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.

Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.